RGEN – repligen corporation (US:NASDAQ)
Stock Stats
News
Repligen Corporation to Present at Upcoming Investor Conferences
Repligen to Report Third Quarter 2024 Financial Results
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release [Yahoo! Finance]
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More [Yahoo! Finance]
Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $205.00 price target on the stock.
Form SC 13G/A REPLIGEN CORP Filed by: BlackRock, Inc.
Form 8-K REPLIGEN CORP For: Sep 12
Form 4 REPLIGEN CORP For: Sep 10 Filed by: Hunt Anthony
Form SC 13G/A REPLIGEN CORP Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form 144 REPLIGEN CORP Filed by: Hunt Anthony
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.